PSA and beyond references
References used in the production of the booklet.
Allen NE, Key TJ, Appleby PN et al. Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer. 2008;98(9):1574-81.
Ben-Shlomo Y, Evans S, Ibrahim F, et al The Risk of Prostate Cancer amongst Black Men in the United Kingdom: The PROCESS Cohort Study. Eur Urol 2008; 53(1):99-105.
Draisma G et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003; 95(12): 868-878.
Edwards SM and Eeeles R. Unravelling the Genetics of prostate cancer. American Journal of Medical Genetics Part C. 2004;129(1):65-73.
Elo JP and Visakorpi T. Molecular genetics of prostate cancer. Ann Med 2001;33(2):130-41.
Etzioni R et al. Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J Natl Cancer Inst. 2002; 94: 981-990.
Gann PH, Giovannucci ED. Nutrition and prostate cancer. CA: Prostate Cancer Foundation; 2005.
Gao X, LaValley MP, Tucker KL Prospective Studies of dairy product and calcium intakes and prostate cancer risk: A meta-anaysis. J Natl Cancer Inst. 2005;97(23):1768-77.
Giovannucci E, Liu Y, Platz EA et al. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int.J Cancer 2007;121 (7):1571-8.
Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU International 2003; 91:789-794.
NICE. Prostate cancer: diagnosis and treatment. 2008.
Office of National Statistics. Death registrations in England and Wales :2006, causes. Health Services Quarterly 34 Summer 2007
PCRMP Guide no1. Undertaking a transrectal ultrasound guided biopsy of the prostate. Dec 2006.
Price CP et al. Pre- and post-analytical factors that may influence the use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer. Ann Clin Biochem 2001;38: 188-216.
Selley S, Donovan J, Faulkner A, Coast J, Gillatt D. Diagnosis, management and screening of early localised prostate cancer. Health Technol Assess 1997;1(2):i, 1-i,96.
Stamey TA et al. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol. 2004; 172: 1297-301.
Thompson IM, Pauler DK, Goodmen PJ et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < 4.0 ng per millilter. N Engl J Med. 2004;350(22):2239-46
World Cancer Research Fund/American Institute for Cancer. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington DC:AICR, 2007
Yao SL, Lu-Yao G. Understanding and appreciating overdiagnosis in the PSA era. J Natl Cancer Inst. 2002; 94: 958-960.